• Accueil >
  • Publications >
  • Pragmatic issues in biomarker evaluation for targeted therapies in cancer

Pragmatic issues in biomarker evaluation for targeted therapies in cancer

1 avr. 2015Nature Reviews Clinical Oncology

DOI : 10.1038/nrclinonc.2014.202

Auteurs

Armand de Gramont, Sarah Watson, Lee M. Ellis, Jordi Rodón, Josep Tabernero, Aimery de Gramont, Stanley R. Hamilton